Program
Friday, September 25, 2020
Cirrhosis and portal hypertension:
from guidelines to individualized approach
08:30 OPENING CEREMONY (Ljubičić N, Ostojić R, Tonkić A, Dolic K, Flisiak R, Puljiz Z, Grgurević I)
09:00-10:30 RECOGNIZING THE PROBLEM
Chairs: Ostojic R, Puljiz Z
Noninvasive tests for fibrosis and cirrhosis: are we ready for screening? (Gines P , ES)
What about steatosis and NAFLD? (Mikolasevic I, HR)
Noninvasive tests of portal hypertension by elastography (Grgurevic I, HR)
How close we are to HCV elimination: data from Central Europe (Flisiak R, PL)
11:00-12:30 PREVENTING THE COMPLICATIONS
Chairs: Flisiak R, Tonkic A
Primary prevention of variceal bleeding and decompensation (Bosch J, ES)
Gut microbioma in progression of cirrhosis and portal hypertension (Papp M, HU)
Treatment of hepatitis C in patients with cirrhosis (Filipec-Kanizaj T, HR)
Treatment of PBC (Jarcuska P, SK)
13:30-15:00 PATIENT WITH ADVANCED CIRRHOSIS AND PORTAL HYPERTENSION I
Chairs: Villanueva C, Milic S
Endoscopic treatment of acute variceal bleeding (Puljiz Z, HR)
Secondary prevention of variceal bleeding: guided or blinded? (Alvarado TE, ES)
The role of TIPS (Patch D/Potts J, UK)
Renal injury in cirrhosis (Knezevic-Stromar I, HR)
15:30-17:00 PATIENT WITH ADVANCED CIRRHOSIS AND PORTAL HYPERTENSION II
Chairs: Hrstic I, Sperl I
Frailty in cirrhosis (Skladany L, SK)
Severe alcoholic hepatitis (Virovic Jukic L, HR)
Long-term outcome of patients with alcoholic liver cirrhosis (Stauber R, AT)
Impact of outpatient care on survival in alcoholic cirrhosis (Tepes B, SI)
17:30-19:00 PERSONALIZED AND PRECISION MEDICINE IN CIRRHOSIS AND PH
Chairs: Bonacin D, Graupera I
Genetic determinants for progression of cirrhosis and portal hypertension (Tsochatzis E, UK)
A new prognostic algorithm to improve risk-stratification after variceal bleeding (La Mura, IT)
Artificial neural network prognostic modeling in cirrhosis (Salkic N, BA)
Screening for HCC (Milovanovic T, RS)